Loader

Pathways

PathWhiz ID Pathway Meta Data

PW145853

Pw145853 View Pathway
drug action

Pitavastatin Drug Metabolism Action Pathway

Homo sapiens

PW146418

Pw146418 View Pathway
drug action

Pitolisant Drug Metabolism Action Pathway

Homo sapiens

PW176951

Pw176951 View Pathway
drug action

Pivampicillin Action Pathway

Escherichia coli
Pivampicillin is a 1-β methyl-carbapenem that is structurally related to beta-lactam antibiotics.5 It was first authorized for use in the US in November 2001 and in Europe in April 2002. Shown to be effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria, ertapenem is used to treat various bacterial infections. Pivampicillin exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs).5 In Escherichia coli, it has a strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preferential binding to PBPs 2 and 3.5 Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW145471

Pw145471 View Pathway
drug action

Pivampicillin Drug Metabolism Action Pathway

Homo sapiens

PW176952

Pw176952 View Pathway
drug action

Pivmecillinam Action Pathway

Escherichia coli
Pivmecillinam is a 1-β methyl-carbapenem that is structurally related to beta-lactam antibiotics.5 It was first authorized for use in the US in November 2001 and in Europe in April 2002. Shown to be effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria, ertapenem is used to treat various bacterial infections. Pivmecillinam exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs).5 In Escherichia coli, it has a strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preferential binding to PBPs 2 and 3.5 Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW145472

Pw145472 View Pathway
drug action

Pivmecillinam Drug Metabolism Action Pathway

Homo sapiens

PW128555

Pw128555 View Pathway
drug action

Pixantrone Action Pathway

Helicobacter pylori
Pixantrone is anaza-anthracenedione and DNA intercalator which inhibits topoisomerase II, used to treat patients with relapsed or refractory aggressive Non-Hodgkin B-cell Lymphomas Pixantrone inhibits DNA gyrase (topoisomerase II). DNA gyrase prevents supercoiling in bacterial DNA. The inhibition of DNA gyrase (topoisomerase II) and topoisomerase IV causes supercoiling of the bacterial DNA. This prevents DNA replication.

PW145670

Pw145670 View Pathway
drug action

Pixantrone Drug Metabolism Action Pathway

Homo sapiens

PW176285

Pw176285 View Pathway
metabolic

Pixantrone Predicted Metabolism Pathway

Homo sapiens
Metabolites of Pixantrone are predicted with biotransformer.

PW145665

Pw145665 View Pathway
drug action

Pizotifen Drug Metabolism Action Pathway

Homo sapiens